Delivery Order SPE2DB22D1017-SPE2DB24FG5AY

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. The contract has a potential value of $10,765.92 and a completion date of February 20, 2024. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary vehicle for the company to deliver...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOPAMAX 100 MG TABLET 60S, with a ceiling value of $2,189.94 and a period of performance through June 13, 2025. The contract is designated as a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, to supply TOPAMAX 50 MG TABLET 60S medication. The $10,915.77 award has an ultimate completion date of April 11, 2024 and is not associated with any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a $12,893.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This delivery order contract has an ultimate completion date of March 18, 2024 and was awarded on March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $3,184.21 contract is for the delivery of TOPAMAX 50 MG TABLET 60S, a prescription medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of Topamax 50 mg tablets, a pharmaceutical product, with a ceiling value of $1,029.00. The contract is a firm-fixed-price delivery order with a period of performance through September 30, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide TOPAMAX 200 MG TABLET 60S, a pharmaceutical product. The $4,075.26 contract has a completion date of February 12, 2024 and does not utilize any set-aside designations. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOPAMAX 200 MG TABLET 60S, a pharmaceutical product, with a total ceiling value of $4,952.28. The contract has an ultimate completion date of November 13, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,737.68 firm-fixed-price contract is for the delivery of TOPAMAX 50 MG TABLET 60S, a medication used to treat certain types of seizures. The contract has an ultimate completion date of June 23, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 200 MG TABLET 60S. The $8,026.69 award has a completion date of January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is also the prime on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG5AY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TOPAMAX 50 MG TABLET 60S. The contract has a ceiling value of $1,029.00 and is a Firm Fixed Price delivery order with a completion date of September 13, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its Corporate Office division, will provide the required pharmaceutical product to support military treatment facilities and other federal healthcare programs served by the DLA. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at up to $999,999,999 through December 2025, for the broad supply of medical commodities to the U.S. military and other government agencies.

Generated 12/12/24, 10:35 AM